← FDA DRUG APPROVALS

FDA ANDA · ANDA078215

SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE

Sponsor: HIKMA

APPLICATION
ANDA078215
TYPE
ANDA
ORIGINAL APPROVAL
2011-03-31
LATEST ACTION
2025-09-09
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSEPrescription
SODIUM FERRIC GLUCONATE COMPLEX EQ 62.5MG IRON/5ML (EQ 12.5MG IRON/ML) · INJECTABLE · INJECTION

Approval history

2025-09-09Labeling · Supplement 9 · standardAP
2025-09-09Labeling · Supplement 11 · standardAP
2025-09-09Labeling · Supplement 14 · standardAP
2012-02-28Labeling · Supplement 1AP
2012-02-28Labeling · Supplement 2AP
2011-03-31OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →